LCAT and neoplasm: As shown in Figure 9A, compared to the LCAT low expression group, the LCAT high expression group has lower immune cell enrichment scores in DLBC, KIRC, KIRP, TGCT, THCA, THYM, UCEC, MESO, and OV tumor samples.